When antidepressants haven’t worked, the question “does TMS actually work?rdquo; deserves a direct answer, not reassurance.
Clinical research behind TMS’s FDA clearance found that treatment-resistant depression patients experienced a clinically meaningful response in many cases, with a substantial share achieving full remission. These findings come from controlled trials, not a guarantee for any individual patient.
This page covers what the evidence shows, how those outcomes compare to alternatives, and what TMS treatment at Scottsdale TMS Therapy involves
What Does the Research Show About TMS Effectiveness?
TMS is a non-invasive treatment that uses targeted magnetic pulses to stimulate underactive areas of the prefrontal cortex involved in mood regulation. The FDA cleared TMS for major depressive disorder in 2008, primarily for patients who have not responded to at least one antidepressant.
The pivotal randomized controlled trial supporting FDA clearance found that active TMS produced significantly greater symptom improvement than sham treatment in patients who had failed a prior antidepressant.
Published research on standard TMS for treatment-resistant depression documents a clinically meaningful response in many patients, with full remission achieved in a substantial subset. A 2022 Stanford study of an accelerated protocol called SAINT found remission in most participants with severe, treatment-resistant depression, though that trial involved only 29 participants and the findings are preliminary.
Your clinical outcome depends on your depression severity, your prior treatment history, and other variables your treatment team assesses before and during care.
What Does “Response” Mean, and How Long Do TMS Outcomes Last?
TMS research uses specific clinical definitions. “Response” means a reduction of at least 50% in depression symptom scores on validated scales such as the Hamilton Depression Rating Scale.
A patient who responds is significantly better but may not be symptom-free. “Remission” means symptom scores have fallen below the threshold for a major depressive disorder diagnosis, a more demanding standard than response. Both outcomes are clinically meaningful, especially for patients whose prior treatments produced little or no change.
Durability matters to patients weighing whether TMS is worth pursuing. A 12-month durability study found that most initial responders maintained at least partial relief at one year, and many maintained full remission without additional treatment.
Re-treatment with TMS restored response for most patients who relapsed. For patients with recurrent or treatment-resistant depression, TMS combined with ongoing therapy and psychiatric care tends to produce better long-term outcomes than TMS alone.
What Is TMS Treatment Like at Scottsdale TMS Therapy?
A standard TMS course involves sessions of 20 to 40 minutes, five days per week, over four to six weeks, for a total of 30 to 36 sessions. During each session, you sit in a chair while a coil positioned near the head delivers magnetic pulses to the targeted brain region, producing a tapping or clicking sensation.
The most common side effect is mild scalp discomfort at the treatment site, particularly during the first few sessions. Headaches, lightheadedness, and muscle twitching can also occur. Seizures are a rare but possible side effect, with higher risk in patients with a personal history of seizures or epilepsy.
You remain awake and alert throughout each session, with no sedation and no recovery period. For patients whose depression involves treatment-resistant features, Scottsdale TMS Therapy also offers Spravato, the FDA-approved intranasal esketamine treatment, administered in-clinic under medical supervision.
Who Responds Best to TMS, and What Happens If It Doesn’t Work?
Patients with less treatment resistance tend to respond at higher rates than patients who have failed five or more medications. Earlier initiation of TMS in the course of a depressive episode is also associated with better outcomes in some research. Co-occurring anxiety disorders do not disqualify a patient from TMS; TMS holds a separate FDA clearance for OCD, and your treatment team will assess how anxiety symptoms interact with your depression and how that should inform your protocol.
If TMS does not produce a meaningful response, it means one treatment approach hasn’t worked, not that no treatment will. The evaluation that follows typically looks at whether the protocol was fully optimized, whether Spravato is appropriate, and whether co-occurring conditions require separate attention. Your treatment team monitors progress at regular intervals throughout treatment, not only at the end of the course, so protocol adjustments can happen during treatment rather than after.
Begin TMS Treatment at Scottsdale TMS Therapy
Every patient starts with a full clinical assessment. The team reviews your diagnosis, prior treatment history, and current medications before designing your TMS protocol.
If you are in crisis, call or text 988.
Call (480) 841-9279 to schedule your consultation.
Scottsdale TMS Therapy 7287 E Earll Drive, Suite 1, Scottsdale, AZ 85251 Hours: 8:00 AM to 8:00 PM